Lupin Pharmaceuticals, Inc.
Lupin Receives US FDA Tentative Approval for Memantine HCl Tablets
Published in Mental Health Business Week, February 6th, 2010
Lupin's Memantine HCl tablets are AB-rated to Namenda® tablets indicated for the treatment of moderate to severe dementia of the Alzheimer's type. Namenda had annual sales of approximately $1.1 billion for the twelve months ended September 2009, based on IMS Health sales data.
Commenting on the approval, Vinita Gupta, President and CEO of Lupin Pharmaceuticals, Inc., said, "We are pleased to receive this tentative approval and look forward to bringing...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Business Week
More Articles from Mental Health Business Week
- Adler School of Professional Psychology
Robert Wood Johnson Foundation Awards Grant to the Adler School's Institute on Social Exclusion for First-Of-Its-Kind Conference on Mental Health Issues - Behavioral Innovations
Behavioral Innovations Expands in Texas with First San Antonio Location - California Healthy Marriages Coalition
California Healthy Marriages Coalition Says Associated Press Article 'Job Loss Impacts Child Support' Doesn't Tell Impact on Taxpayers - CITGO Petroleum Corporation
Lakeview Pantry Wins Year's Supply of Gas in CITGO Fueling Good Program - Clinical Trial Research
ABC Publishes Monograph on Scientific and Clinical Research of Pycnogenol(R) - Dakim, Inc.
Dakim BrainFitness Adopted by Arizona State Veteran Home - More from this issue of Mental Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
